The improvement in hepatic fibrosis was associated with IL28B CC genotype, zinc supplementation, pre-treatment early fibrosis stages (Table 2), and triple therapeutic regimen (Fig. 3A). This evidence concerns the gene IFNL3 and Hepatic fibrosis.